X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 04/Sep 16:59

Novel intermediate form of serotonin receptor identified as therapeutic target for psychiatric disorders

Misha Kudryshev's lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as depression and schizophrenia.

Articles similaires

Novel intermediate form of serotonin receptor identified as therapeutic target for psychiatric disorders

news.medical.net - 04/Sep 16:59

Misha Kudryshev's lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as...

A promising new therapeutic target for MASLD identified

news.medical.net - 11/Sep 06:08

Using a novel stem cell platform, a team of the Medical University of South Carolina researchers has identified a pathway that could be targeted by...

Researchers identify key markers in pancreatic cancer progression using a new analysis pipeline

oncologynews.com.au - 02/Sep 15:57

Using a new workflow that integrates spatial transcriptomics and machine learning for imaging analysis and integration with single-cell datasets,...

MYO1D mutation identified as a key factor in sperm defects and congenital conditions

news.medical.net - 03/Sep 02:56

The research uncovers a novel variant in the MYO1D gene that is linked to laterality defects, congenital heart diseases, and sperm defects in humans.

Sorry! Image not available at this time

Stealth BioTherapeutics to receive FARA grant to develop investigational mitochondrial therapeutic SBT─589 for Friedreich's ataxia

pharmabiz.com - 13/Sep 16:48

Stealth BioTherapeutics Inc., a clinical─stage biotechnology company focused on the discovery, development and commercialization of novel therapies...

Sorry! Image not available at this time

Stealth BioTherapeutics to receive FARA grant to develop investigational mitochondrial therapeutic SBT─589 for Friedreich's ataxia

pharmabiz.com - 13/Sep 16:48

Stealth BioTherapeutics Inc., a clinical─stage biotechnology company focused on the discovery, development and commercialization of novel therapies...

Sorry! Image not available at this time

Study finds Alzheimer’s-like brain changes in long COVID patients

knowridge.com - 03/Sep 10:20

New research from the University of Kentucky’s Sanders-Brown Center on Aging has revealed that the cognitive impairments seen in long COVID patients...

Long COVID inflicts deep scars on the lungs, targeting specific cells could reverse damage

rawstory.com - 09/Sep 15:26

The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...

Long COVID inflicts deep scars on the lungs, targeting specific cells could reverse damage

rawstory.com - 09/Sep 15:26

The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...

Dyslexia In Australian Schools: Identifying The Problem – OpEd

eurasiareview.com - 01/Sep 23:04

According to the Australian Dyslexia Association, “Dyslexia is estimated to affect some 10% of the Australian population.” This squarely puts...

Les derniers communiqués

  • Aucun élément